BANK OF AMERICA CORP /DE/ - TETRAPHASE PHARMACEUTICALS I ownership

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2020$37,000
+164.3%
14,730
+34.5%
0.00%
Q1 2020$14,000
-30.0%
10,951
+54.3%
0.00%
Q4 2019$20,000
-31.0%
7,099
+29.4%
0.00%
Q3 2019$29,0005,4880.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2020
NameSharesValueWeighting ↓
CVI Holdings, LLC 208,074$524,0000.19%
ARMISTICE CAPITAL, LLC 1,419,507$3,577,0000.16%
Tekla Capital Management LLC 42,965$108,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 30,000$76,0000.00%
ACADIAN ASSET MANAGEMENT LLC 78,218$197,0000.00%
UBS Group AG 2,925$7,0000.00%
Sargent Bickham Lagudis LLC 1,000$3,0000.00%
Sowell Financial Services LLC 1$00.00%
OSAIC HOLDINGS, INC. 150$00.00%
DIMENSIONAL FUND ADVISORS LP 12,664$32,0000.00%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders